Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

Assistance Publique Hopitaux De Marseille1 site in 1 country143 target enrollmentJune 2008

ConditionsCoronary Syndrome

Overview

Phase: N/A
Intervention: Not specified
Conditions: Coronary Syndrome
Sponsor: Assistance Publique Hopitaux De Marseille
Enrollment: 143
Locations: 1
Primary Endpoint: To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Registry

clinicaltrials.gov

Start Date

June 2008

End Date

August 2011

Last Updated

11 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Assistance Publique Hopitaux De Marseille

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•subjects over 18 years,
•subject about having a chest pain of coronary syndrome,
•subject about not having received heparin or LMWH

Exclusion Criteria

•subject minor
•subject without informed consent,
•subject after receiving an anticoagulant treatment,
•transplanted heart, kidney or liver

Outcomes

Primary Outcomes

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Time Frame: 24 months